kw.\*:("ICRF 154")
Results 1 to 10 of 10
Selection :
DER EINFLUBETA DER BIS-DIOXOPIPERAZINE ICRF 159 UND ICRF 154 AUF DIE CADMIUM-AUSSCHEIDUNG IM URIN BEI CADMIUM-VERGIFTETEN RATTEN = EFFET DES BIS-DIOXOPIPERAZINES ICRF 159 ET ICRF 154 SUR L'EXCRETION URINAIRE DU CADMIUM CHEZ LES RATS INTOXIQUES AU CADMIUMWITTING U; BERTRAM HP; SCHUMACHER E et al.1979; INTERNATION. ARCH. OCCUP. ENVIRONMENT. HEALTH; DEU; DA. 1979; VOL. 42; NO 3-4; PP. 365-373; ABS. ENG; BIBL. 11 REF.Article
STUDIES ON THE STABILITY AND CELLULAR DISTRIBUTION OF DIOXOPIPERAZINES IN CULTURED BHK-21 S CELLS.DAWSON KM.1975; BIOCHEM. PHARMACOL.; G.B.; DA. 1975; VOL. 24; NO 24; PP. 2249-2253; BIBL. 24 REF.Article
Bioinorganic interactionsCollection sécurité. 1984, Vol 15, Num 3-4, pp 448-453, issn 0538-4818Article
Inhibition of intracellular topoisomerase II by antitumor bis(2,6-dioxopiperazine) derivatives : mode of cell growth inhibition distinct from that of cleavable complex-forming type inhibitorsISHIDA, R; MIKI, T; NARITA, T et al.Cancer research (Baltimore). 1991, Vol 51, Num 18, pp 4909-4916, issn 0008-5472Conference Paper
Evidence from studies with intact mammalian cells that merbarone and bis(dioxopiperazine)s are topoisomerase II poisonsSNYDER, Ronald D.Drug and chemical toxicology (New York, NY. 1978). 2003, Vol 26, Num 1, pp 15-22, issn 0148-0545, 8 p.Article
Bis(2,6-dioxopiperaxine) derivatives, topoisomerase II inhibitors which do not form a DNA cleavable complex, induce thymocyte apoptosisONISHI, Y; AZUMA, Y; KIZAKI, H et al.Biochemistry and molecular biology international. 1994, Vol 32, Num 1, pp 115-122, issn 1039-9712Article
Antitumor activity of MST-16, a novel derivative of bis(2,6-dioxopiperazine), in murine tumor modelsNARITA, T; FYAGUCHI, S.-I; KOMATSU, T et al.Cancer chemotherapy and pharmacology. 1990, Vol 26, Num 3, pp 193-197, issn 0344-5704, 5 p.Article
The effects of ICRF-154 in combination with other anticancer agents in vitroKANO, Y; NARITA, T; SUZUKI, K et al.British journal of cancer. 1992, Vol 66, Num 2, pp 281-286, issn 0007-0920Article
Inhibition of topoisomerase II by antitumor agents bis(2,6-dioxopiperazine) derivativesTANABE, K; IKEGAMI, Y; ISHIDA, R et al.Cancer research (Baltimore). 1991, Vol 51, Num 18, pp 4903-4908, issn 0008-5472Conference Paper
Translocation t(7;11)(P15;P15) in a patient with therapy-related acute myeloid leukemia following bimolane and ICRF-154 treatment for psoriasisXUE, Y; GUO, Y; XIE, X et al.Leukemia research. 1997, Vol 21, Num 2, pp 107-109, issn 0145-2126Article